AI
MIRM icon

AdvisorShares Investments’s Mirum Pharmaceuticals MIRM Stock Holding History

AdvisorShares Investments’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-13,100
Closed -$288K – 261
2022
Q1 		$288K Buy
+13,100
New +$267K 0.05% 145

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AdvisorShares Investments's MIRM Position: Q2 2022 in Review

AdvisorShares Investments sold out of Mirum Pharmaceuticals (MIRM) in Q2 2022, closing a stake of 13,100 shares — an estimated $288K sold.

AdvisorShares Investments first reported a position in MIRM in Q1 2022 and held it in 1 quarter. The position peaked at $288K in Q1 2022. 109 funds tracked by Wall St. Rank hold MIRM as of Q2 2022.

  • AdvisorShares Investments reported no remaining Mirum Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • AdvisorShares Investments sold 13,100 Mirum Pharmaceuticals shares in Q2 2022, an estimated $288K.
  • AdvisorShares Investments first reported a position in Mirum Pharmaceuticals in Q1 2022 and held it in 1 quarter.
  • AdvisorShares Investments's Mirum Pharmaceuticals position peaked at $288K in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2022.

Based on AdvisorShares Investments's 13F filing for Q2 2022, filed 8 Aug 2022.